Moran Levy was a Visiting Research Fellow with the Program on Science, Technology and Society at the Harvard Kennedy School of Government, and a PhD Candidate in the Sociology Department at Columbia University. Her current research examines how the emergence of cancer as a leading cause of death in the U.S. has transformed the institutions of medical research and care. Her work traces how the failure to cure cancer and the need to detect elusive and marginal effects of highly toxic chemotherapeutics led researchers to mesh together medicine and statistics and to construct new infrastructure for producing medical evidence. In particular, her work examines the emergence of large-scale randomized clinical trials. While at Harvard, Moran is focusing on the relation between the standardization of cancer trials and oncological diagnostic classifications.

In a different project, also focusing on epistemic structure in medicine and on randomized clinical trials, Moran examines how placebo effects, traditionally the backdrop of biomedical knowledge, are becoming themselves an object of research studied in randomized controlled trials.